Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American Patients
Update: 2025-10-01
Description
Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American Patients
Key Points:
- Access for States: All state Medicaid programs will gain access to MFN prices on Pfizer medicines, saving millions of dollars.
- Patient Discounts: Patients purchasing directly will see major reductions, including:
- Foreign Revenue & Innovation: Agreement requires Pfizer to repatriate increased foreign revenue resulting from U.S. trade policy, deliver MFN pricing on all new innovative medicines, and ensure deep discounts for American patients.
- Ending Global “Freeloading”:
- Fulfilling Promises:
Takeaway:
This deal marks the first time a major pharmaceutical company has agreed to MFN pricing, setting a precedent for lowering drug costs, protecting U.S. patients, and ending reliance on Americans to subsidize low drug prices abroad.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
